Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD, MS
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Children'S Hospital and Research Center Oakland
Oakland, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Indiana University Medical Center/ Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Louisville/kosair Children'S Hospital
Louisville, Kentucky, United States
- Johns Hopkins Unversity
Baltimore, Maryland, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute/children'S Hospital of Michigan
Detroit, Michigan, United States
- Children'S Mercy Hospital and Clinics
Kansas City, Missouri, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Penn State College of Medicine/the Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas/md Anderson Cancer Center
Houston, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Children'S Hospital of Wisconsin/midwest Children'S Cancer
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jul 2017
- Primary completion
- 17 Aug 2021
- Completion
- 17 Aug 2021
- Last update posted
- 31 Mar 2026
- Registered enrollment
- 32
- Registry id
- NCT02918292
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.